Sterile water for injection (SWFI) is USP-grade water filtered, distilled or reverse-osmosis purified, and packaged in single-use sterile containers. Unlike bacteriostatic water, SWFI carries no preservative and is labelled for one-time use only — any volume drawn from a SWFI vial that is not immediately used must be discarded.
Definition
Sterile water for injection is a USP-monographed parenteral diluent. The specification covers source-water quality (Water for Injection, produced by distillation or reverse osmosis meeting USP-NF requirements), terminal sterilisation, particulate and endotoxin limits, and packaging in sterile containers with integrity verification. The defining feature against the closely-related bacteriostatic water for injection is the absence of any added preservative — SWFI contains only purified water and the sealed sterile vial is the sole barrier against microbial contamination.
The single-use labelling follows directly from the no-preservative composition. Once the vial seal is broken to draw fluid, the sterile barrier is compromised and any volume that remains in the vial is at risk of microbial growth from the moment of the first puncture. Operationally, SWFI is the diluent of choice when the peptide or biologic to be reconstituted is incompatible with benzyl alcohol, when the experimental workflow does not require multi-dose draws from a single vial, or when single-use parenteral handling is specifically required by the downstream protocol.
How SWFI compares to bacteriostatic water in peptide research
For research-peptide reconstitution, bacteriostatic water is the operational default because most research protocols involve drawing successive doses from a single reconstituted vial across days or weeks of an experiment. SWFI is the alternative when one of two conditions applies: the compound is known or suspected to be incompatible with benzyl alcohol (a small set of peptide chemistries show measurable degradation in the preservative’s presence), or the experimental design specifically requires a preservative-free diluent. In the SWFI workflow each vial is reconstituted, the full volume is drawn and used immediately, and any residue is discarded.
The aliquoting + freezing strategy is sometimes used to extend an SWFI workflow across multiple sessions by reconstituting a stock with SWFI, immediately dispensing into single-use aliquot tubes, freezing the aliquots, and thawing one aliquot per session. This adds a freeze-thaw stress that the bacteriostatic-water workflow avoids, and the trade-off between freeze-thaw exposure and preservative-compatibility is the engineering decision specific to each compound. Detailed protocols are in the peptide storage guide.
Related terms
- Bacteriostatic water
- Aliquot
- Freeze-thaw cycle
- Lyophilized
- Water for Injection (WFI)
- Endotoxin / LAL test
- Reconstitution
Where SWFI appears in the Ronin workflow
SWFI is the alternative diluent for the small set of catalog compounds where benzyl-alcohol incompatibility is documented or suspected. Compound-specific diluent recommendations are in the Reconstitution and laboratory handling accordion on each product page and in the reconstitution guide.
References
- USP Sterile Water for Injection monograph — composition, sterility, endotoxin, particulate, and packaging specifications.
- USP <1231> Water for Pharmaceutical Purposes — definitions of Water for Injection and the parenteral-grade water hierarchy.
- FDA Compounding Guidance — single-use vial handling for non-preserved parenteral diluents.
Glossary entries describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.